Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 496

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 496
---
 file its annual report on Form 20 -Fwith the SEC no later than four months following its fiscal year end. APx files annual, quarterly and current reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read APx’s SEC filings, including this proxy statement/prospectus, over the Internet at the SEC’s website at http: // www.sec.gov. All documents subsequently filed by APx pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the date on which the special meeting is held, shall be deemed to be incorporated by reference into this proxy statement/prospectus. If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the proposals to be presented at the Special Meeting, you may request copies of this proxy statement/prospectus and any other publicly available information concerning Bridgetown, without charge, by written or oral request, to: Telephone: (202) 465 -5882
APx Acquisition Corp. I 714 Westview Avenue Nashville, TN 37205 You may also obtain these documents by requesting them in writing or by telephone from APx’s proxy solicitation agent at the following address, telephone number and email: [•]
P.O. [•]
[•]
Attn: [•]
Toll Free Telephone: [•]
Main Telephone: [•]
E -mail: [•] If you are a shareholder of APx and would like to request documents, please do so by, 2025 to receive them before the special meeting. If you request any documents from us, we will mail them to you by first class mail, or another equally prompt means. All information in this proxy statement/prospectus relating to APx has been supplied by APx, and all such information relating to the Company has been supplied by the Company. Information provided by either APx or the Company does not constitute any representation, estimate or projection of any other party. The Company does not file any annual, quarterly and current reports, proxy statements and other information with the SEC. The Company’s website address is www.omnigenics.ai. None of the Company or APx has authorized anyone to give any information or make any representation about the Business Combination or their companies that is different from, or in addition to, that contained in this proxy statement/prospectus or in any of the materials that have been incorporated in this proxy statement